Shares of Anthera Pharmaceuticals, Inc. (ANTH) plunging more than 8% in early trading as cautious StreetSweeper article, which calls the company “another cash-poor, bubbly biotech about to blow apart”, makes the rounds. The articles concludes, that based on analyst/doctor’s assessment of “Anthera’s product, blisibimod for lupus, is valueless, and we agree that the stock is […]
View the full post at: Anthera (ANTH) Drops 8% On StreetSweeper Cautious Article